Cellular Biomedicine Group to Present on Three Panels at B. Riley FBR Annual Healthcare Conference
Benzinga 28, 2018 (GLOBE NEWSWIRE) — Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged
Read more